$46.17 -0.43 (-0.92%)
2/10/2012 4:01 PM

Covance, Inc. (NYSE:CVD)

CAPS Rating: 3 out of 5

A drug development services company providing a range of early stage and late stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries.

Featured Broker Partners


Advertisement